PROGRAMME Postgraduate Course
EHMSG Postgraduate Course
“Gut microbiome: news in diagnostics and therapeutics”
September 11, 2025
Course directors: Francesco Franceschi, Antonio Gasbarrini, Gianluca Ianiro
08.30 – 09.00 Registration
09.00 – 09.15 Welcoming
Course Directors
09.15 – 10.30 Session I: Gut microbiome diagnostics
Chairs: Giovanni Cammarota, Maurizio Sanguinetti
09.15 - 09.40 hrs
01.01. Gut microbiome testing in oncology
Laurence Zitvogel, Paris, France
09.40 - 10.05
01.02. Gut microbiome testing in chronic noncommunicable disorders
Siew Ng, hong Kong, China
10.05 - 10.30 hrs
01.03. Standardizing gut microbiome testing: ready for prime time?
Serena Porcari, Italy
10.30 - 11.00 Coffee Break
11.00 - 12.15 Session II: Beyond gut microbiome diagnostics
Chair: Peter Malfertheiner, Munich, Germany, Sinead Smith, Dublin, Ireland
11.00 - 11.25 hrs
02.01. Breath testing for the evaluation of gut ecosystems: from lactulose and Urea to Breathomics
Loris Riccardo Lopetuso, Italy
11.25 - 11.50 hrs
02.02. Metabolomics: challenges and opportunities
Rinse K. Weersma, Netherlands
11.50 - 12.15 hrs
02.03. Microbial diagniostics in other body sites
Lars Engstrand, Stockholm, Sweden
12.15 - 13.15 hrs | Lunch break
13.15 - 14.30 | Session III: Therapeutic modulators of gut microbiome: antibiotics, pre- and probiotics
Chair: Carmelo Scarpignato, Lorenza Putignani
13.15 - 13.40 hrs
03.01. Advancing probiotics to the next level
Giovanni Barbara, Bologna, Italy
13.40 - 14.05 hrs
03.02. Which prebiotics in the therapeutic armamentarium of clinicians?
Maria Carmen Collado, Spain
14.05 - 14.30 hrs
03.03. Antibiotics for gut microbiota
Francesca Romana Ponziani, Italy
14.30 - 15.00 | Coffee-break
15.00 - 16.15 | Session IV: Therapeutic modulators of gut microbiome: FMT and beyond
Chair: Josbert Keller, Mirjana Rajilic-Stojanovic, Belgrade, Serbia
15.00 - 15.25 hrs
04.01. FMT: what’s new
Nicolas Benech, France
15.25 - 15.50 hrs
04.02. An ecological approach to gut microbiota modulation
Jens Walter, Ireland
15.50 - 16.15 hrs
04.03. Current landscape of artificial microbiome therapeutics
Benjamin Mullish, United Kingdom
16.15 - 16.25 Closing
Course Directors